Speaker

Ebony Dashiell-Aje, PhD is a leading expert in patient-centered outcomes research, including clinical outcome assessment (COA) and digital health technology development and optimization, measurement science strategy, and patient engagement across the medical product lifecycle. Currently, she serves as the Executive Director & Head of Patient-Centered Outcomes Science at BioMarin. Dr. Dashiell-Aje and has also served within the Division of Clinical Outcome Assessment (DCOA) in the Office of New Drugs at FDA as a scientific lead and consultant to CDER, CBER, and CDRH; she was a key player in shaping patient-focused drug development (PFDD) policy efforts. In addition, she has served as expert consultant to both pharmaceutical industry and federal government clients. As a health outcomes researcher and methodologist, Dr. Dashiell-Aje is driven by her passion for public health and promoting patient-centered medical product development, commercialization, and clinical care. Her research expertise has significantly contributed to evidence-based solutions and has helped shape health policy in multi-stakeholder environments.